
    
      This was a two-arm, multi-center, Post Marketing Observational Study (PMOS) conducted in
      Japanese participants with Rheumatoid Arthritis (RA) who continued the one year observational
      period of study P12-069 (HOPEFUL II study; NCT01163292) and provided informed consent to
      participate in study P12-707 (HOPEFUL III study; NCT01346501), after completion of study
      M06-859 (HOPEFUL I study; NCT00870467). The study P12-707 provided an additional two years of
      observation for those participants who participated in study P12-069.
    
  